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OBJECTIVES This study was conducted to develop a time-efficient tilt table test.
BACKGROUND Current protocols of tilt table testing are quite time-consuming. This study was designed to
assess the diagnostic value, tolerance and procedural time of a single-stage isoproterenol tilt
table protocol.
METHODS A single-stage isoproterenol tilt table test was compared with the passive tilt table test. The
study was prospectively designed in a randomized and crossover fashion.
RESULTS The study population consisted of 111 patients with a history of syncope (mean age 55 6 20
years). Of the total, 62 patients (56%; 95% confidence interval, 46% to 65%) had a positive
vasovagal response during isoproterenol tilt table testing and 35 (32%; 23% to 41%) during
passive tilt table testing (p 5 0.002). The mean procedural times of the study population were
11.7 6 3.6 min and 36.9 6 13.3 min for isoproterenol and passive tilt table testing,
respectively (p , 0.001). All patients tolerated single-stage isoproterenol testing. In the 23
control subjects (mean age 34 6 11 years), the apparent specificities were 91% (72% to 99%)
and 83% (61% to 99%) for passive and single-stage tilt table testing, respectively.
CONCLUSIONS The single-stage isoproterenol tilt table test was more effective in inducing a positive
vasovagal response in an adult population than the standard passive tilt table test, and it
significantly reduced the procedural time. The increase in positive yield was associated with
a moderate decrease in apparent specificity. These observations support the conclusion that
single-stage tilt table testing could be a reasonable diagnostic option in patients undergoing
syncope evaluation. (J Am Coll Cardiol 1999;33:985–90) © 1999 by the American College
of Cardiology
Upright tilt table testing has been well-established as a
provocative maneuver in patients with unexplained syncope
(1–10). The sensitivity and specificity of tilt table testing in
detecting vagally mediated syncope are difficult, if not
impossible, to determine, because the true incidence of
vasovagal syncope is unknown in most patient groups and
diagnosis is usually based on a history of typical prodrome
and the exclusion of other conditions. Despite the short-
comings of passive tilt table testing, data accumulated in the
literature suggest that tilting at angles between 60° and 80°
for at least 45 min provides acceptable test outcomes
(4,11–13).
The addition of isoproterenol infusion to standard tilt
table testing has been advocated as a means of increasing the
sensitivity of the test (14–17). This is most likely accom-
plished at the expense of specificity. Several studies have
reported that isoproterenol-induced vasovagal response dur-
ing tilt table testing can be significantly less specific,
especially in younger patients and with higher doses of
isoproterenol (13,18–20). Recent studies suggest that infu-
sion of lower doses of isoproterenol does not significantly
compromise the specificity of the test (12,13). It has been
reported that a single-stage isoproterenol tilt table test could
be less time-consuming (16). Comparisons with the stan-
dard passive tilt and validations in normal controls have not
been performed.
In this prospective study, a single-stage isoproterenol tilt
table test was compared, in a randomized fashion, with the
standard passive tilt table test for clinical usefulness. An
intermediate dose and a shorter duration of the isoproterenol
tilt table protocol were tested in adults with the final goals of
reducing testing time and providing comparable positive yields
without significantly compromising specificity of the test.
From the *Division of Cardiovascular Diseases and Internal Medicine and the
†Section of Biostatistics, Mayo Clinic and Mayo Foundation, Rochester, Minnesota.
This study was supported by National Institutes of Health grant PPG NS32352.
Manuscript received June 11, 1998; revised manuscript received September 16,
1998, accepted December 4, 1998.
Journal of the American College of Cardiology Vol. 33, No. 4, 1999
© 1999 by the American College of Cardiology ISSN 0735-1097/99/$20.00
Published by Elsevier Science Inc. PII S0735-1097(98)00658-5
METHODS
Patient selection. Between January 1996 and June 1997, a
total of 111 patients undergoing tilt table testing for
evaluation of syncope were enrolled in the study. Each
patient had at least one episode of syncope or presyncope.
The cause remained uncertain despite comprehensive med-
ical and neurologic evaluation when appropriate. Patients
with orthostatic hypotension, significant anemia (hemoglo-
bin value of ,11 g/dl), and endocrinologic abnormalities,
such as diabetes, hypoglycemia or thyroid dysfunction, were
excluded from the study. Patients with abnormal findings
during electrophysiologic testing (21) (defined as carotid
sinus hypersensitivity, sinus node dysfunction, atrioventric-
ular conduction system disease or sustained ventricular
arrhythmias correlated with the patient’s clinical symptoms)
were also excluded from the study. Twenty-three normal
subjects with no history of syncope or presyncope under-
went identical testing protocols and served as controls. The
study was approved by the Mayo Clinic Institutional Review
Board. Informed oral consent from all patients and written
consent from all normal controls were obtained before tilt
table testing.
Study protocol. Electrocardiographic (ECG) limb leads I,
II, III, aVF, V1 and V6 were continuously monitored.
Arterial pressure was monitored by an intra-arterial cathe-
ter. Recordings were saved to computer (EP Lab and
BioMed Medical Manufacturing, Irvine, California).
All studies were performed with the subject in the fasting
state for 6 to 10 h. The study protocol (Fig. 1) consisted of
a standard passive tilt table test for 45 min at an angle of 70°
and a single-stage isoproterenol tilt table test with a con-
stant infusion of isoproterenol at 0.05 mg/kg/min (not
exceeding the highest dose at 5 mg/min) for 5 min in the
supine position and then 10 min in the tilted position at a
70° angle. Each patient and control subject underwent both
tilt table testing protocols. The sequence of the passive tilt
table test and isoproterenol tilt table test was randomized. A
minimum interval of 10 min in the supine position to
achieve steady-state hemodynamics was interspersed be-
tween the two tilt table tests. The second test in sequence
began when blood pressure and heart rate returned to within
10% of baseline values. If a vasovagal response was induced
during any stage of the test protocol, the subject was
immediately returned to the supine position. Regardless of
the response of the subject during the first sequence of the
test protocol, the second sequence of tilt table testing
proceeded after complete recovery of the subject.
A positive response was defined as provocation of a
vasovagal reaction during either or both of the testing
protocols. A vasovagal response was defined as the devel-
opment of syncope or presyncope in association with relative
bradycardia (a decrease in heart rate of at least 20% from the
steady-state rate immediately preceding the development of
symptoms) or hypotension (a minimum decrease in systolic
pressure of 30 mm Hg), or both. Because of the sequential
design of the study, preparation times for the two tests could
not be separated from each other. The procedural time for
the passive tilt table test was defined as the period from the
beginning of tilt to the resumption of the supine position.
The procedural time for the single-stage isoproterenol test
was defined as the interval from the time the isoproterenol
infusion was begun in the supine position to the time the
patient was returned to the supine position from tilting.
Statistics. To determine whether the results of the single-
stage isoproterenol tilt table test were significantly different
from those of the passive tilt table test, a McNemar’s test
was completed. A paired t test was used to compare
variables between the isoproterenol test and passive tilt.
Differences between groups were compared for categorical
variables by use of the chi-square test for independence. For
continuous variables, differences between groups were com-
pared by use of the two-sample t test. A p value of ,0.05
was considered significant.
Figure 1. The tilt table protocol includes both passive tilt and single-stage isoproterenol tilt table testing performed sequentially. The
sequence of testing was randomized. Details are given in the text.
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RESULTS
Demographics. The clinical characteristics of the patients
are summarized in Table 1. The mean age (6 SD) of the
111 patients was 55 6 20 years (median 60 years; range 17
to 85 years). There were 56 male and 55 female patients. All
patients had a history of syncope (98 patients) or recurrent
presyncope (13 patients). The mean number of episodes of
syncope in the 1 year before tilt table testing was 3 6 5
(median 2; range 1 to 28), documented in 98 patients. None
of the patients had organic heart disease. The mean left
ventricular ejection fraction was 0.61 6 0.06 in the 70
patients in whom it was measured.
Test outcome. Of the study patients, 62 (56%; 95%
confidence interval [CI], 46% to 65%) had a positive
vasovagal response during isoproterenol tilt table testing, 35
(32%; 23% to 41%) had a positive response during passive
tilt table testing, and 70 (63%; 53% to 72%) had a positive
response during either of the two tests (Table 2). Of the 70
patients with at least one positive response, 62 (89%; 79% to
95%) had the response during isoproterenol tilt table test-
ing, 35 (50%; 38% to 62%) during passive tilt table testing,
and 27 (39%; 27% to 51%) during both tests.
Outcomes were significantly different (p 5 0.002) be-
tween the two tests. The positive response rate was signif-
icantly higher during isoproterenol tilt table testing than
during passive tilt table testing. Of the 35 patients with a
positive response during passive tilt table testing, 27 (77%;
60% to 90%) had the same response during isoproterenol tilt
table testing. Of the 62 patients with a positive response
during isoproterenol tilt table testing, 27 (44%; 31% to 57%)
had the same response during passive tilt table testing.
Factors influencing tilt table response. The effects of
testing sequence, age and gender on the tilt table response were
examined. Sequence of the testing protocol had no signifi-
cant effect on the response to isoproterenol tilt table testing
(p 5 0.4). For passive tilt table testing, a trend was noted
toward a higher positive response rate when passive tilt was
second in the sequence, but it was not statistically significant
(p 5 0.06). Age did not affect the testing outcomes. The
mean age was 54 6 20 years for the 62 patients who had a
response to isoproterenol and 56 6 20 years for the 49 who
did not have a response (p 5 0.7). The mean ages were 53 6
20 years for the 35 patients with a response to passive tilt
and 56 6 19 years for the 76 without a response (p 5 0.4).
When age was dichotomized at 40 years, the response
patterns were not significantly different in either age group.
Patterns of response according to gender were assessed.
During isoproterenol tilt table testing, 29 male patients
(52%; 38% to 65%) and 33 female patients (60%; 46% to
73%) had a positive response (p 5 0.4). During passive tilt
table testing, 14 male patients (25%; 14% to 38%) and 21
female patients (38%; 25% to 52%) had a positive response
(p 5 0.1). Among the subjects with positive responses, 20
male (69%; 49% to 85%) and 15 female (45%; 28% to 64%)
patients required isoproterenol to elicit a positive response
(p 5 0.06).
Time associated with tilt table testing. For the total study
population, the mean procedural time was 11.7 6 3.6 min
(all procedural times reported for the isoproterenol test
included 5 min in the supine position during initiation of
isoproterenol infusion) for isoproterenol and 36.9 6
13.3 min for passive tilt table testing (p , 0.001). Among
the responders, the mean time to a positive response after
tilting was 4.0 6 2.8 min during isoproterenol and 19.3 6
10.5 min during passive tilt table testing (p , 0.001). For
the 27 patients with a positive response during both tests,
time to the response was significantly shorter (p , 0.001)
during isoproterenol (3.4 6 2.8 min) than during passive
(18.4 6 10.4 min) tilt table testing.
Hemodynamic response during tilt table testing. Hemo-
dynamic responses during the two test protocols are sum-
marized in Table 3. Among the 27 patients with a positive
response during both tests, heart rate was significantly
higher (p , 0.001) during isoproterenol (102 6 19 beats/
min) than during passive (72 6 13 beats/min) tilt table
testing in the supine position. Although systolic blood
pressure was not significantly different (p 5 0.8), diastolic
pressure was significantly lower (p 5 0.02) during isopro-
terenol than during passive tilt table testing in the supine
position before any symptoms developed. At the time of
syncope, heart rate, systolic blood pressure, and diastolic
blood pressure were significantly lower during passive tilt
table testing than during isoproterenol tilt table testing.
Results in normal control subjects. A total of 23 normal
subjects were enrolled in the current study. The mean age
was 34 6 11 years. There were 13 male and 10 female
patients. A positive response was elicited in four subjects
(17%; 5% to 39%; three male and one female) during
Table 1. Patient Characteristics
Total no. of patients 111
Female patients, no. (%) 55 (50)
Age (yrs) 55 6 20
Syncope, no. (%) 98 (88)
Episodes in 1 yr, no. 3 6 5 (range 1–28)
Ejection fraction 0.61 6 0.06 (n 5 70)
Table 2. Passive Compared With Single-Stage Isoproterenol
Tilt Table Testing
Passive Tilt
Total No.
of PatientsNegative Positive
Isoproterenol tilt
Negative 41 8 49 (44%)
Positive 35 27 62 (56%)
Total no. of patients 76 (68%) 35 (32%) 111
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isoproterenol and two subjects (9%; 1% to 28%; both male)
during passive tilt table testing.
DISCUSSION
Major findings. In this prospective, randomized study, a
single-stage isoproterenol tilt table test and the standard
passive tilt table test were compared for clinical utility. In
the patient population, inducibility of a vasovagal response
was significantly higher during isoproterenol than during
passive tilt table testing (56% [46% to 65%] vs. 32% [23% to
41%], p 5 0.002). Among those with a positive response
during passive tilt table testing, 77% (60% to 90%) had
syncope reproduced by isoproterenol tilt table testing.
Among those with a positive response during isoproterenol
tilt table testing, 44% (31% to 52%) had syncope reproduced
by passive tilt table testing.
In the normal controls, a vasovagal response was induced
in 17% (5% to 39%) during isoproterenol and 9% (1% to
28%) during passive tilt table testing. Procedural time was
significantly shorter during the single-stage isoproterenol
tilt table test. All patients and control subjects were able to
tolerate the unit dose of isoproterenol infused (0.05 mg/kg/
min). These results suggest that the single-stage isoproter-
enol tilt table test can be effective in inducing a vasovagal
response in susceptible patients and can do so in signifi-
cantly less time than the passive tilt table test. The single-
stage isoproterenol tilt table test is a reasonable diagnostic
option in patients undergoing syncope evaluation.
Passive tilt table testing. It has been proposed that upright
tilting from a supine position precipitates a vasovagal
response in a predisposed patient. Normal physiologic
response includes the proper hemodynamic adjustment to
venous pooling associated with gravitational stress; blood
pressure is stabilized by an increase in heart rate and
contractility as well as by peripheral vasoconstriction
(22,23). In predisposed persons, this stimulus presumably
results in an abrupt withdrawal of various degrees of
peripheral sympathetic tone, causing hypotension or a
sudden surge of vagal discharge resulting in bradycardia, or
both.
It has been well-recognized that the “sensitivity” of tilt
table testing for the diagnosis of vasovagal syncope cannot
be determined, because the clinical diagnosis is usually
presumptive and the cause of syncope in patients undergo-
ing tilt table testing is usually unknown. Depending on the
selected patient population and tilt table protocol, it has
been estimated that during passive tilt table testing, a
vasovagal response develops in 25% to 75% of patients with
unexplained syncope (3,6,8,10,24,25). A study by Fitz-
patrick et al. (4) reported that the mean time to syncope was
24 6 10 min when the tilt was at 60°. From this observa-
tion, it was suggested that the minimum duration of a tilt
table test should be 45 min (mean time to syncope 6 2 SDs).
The specificity of tilt table testing is defined by the
portion of the subjects who have never fainted and have had
a negative test result. Most passive tilt studies have been
conducted at a 60° angle (3,8,10,24), and specificity has
ranged from 90% to 100%. Natale et al. (13) reported
decreased specificity during tilt table testing at 80° compared
with that at 60° and 70° angles.
From the data reviewed above, the “standard” passive tilt
table test used in our laboratory since January 1996 and for
the current study has been at a 70° angle for 45 min. Results
from the current study are comparable with those in
previous reports. A vasovagal response was induced in 33%
of adult patients with syncope that remained unexplained
after comprehensive medical evaluation. A vasovagal re-
sponse was induced in 9% (1% to 28%) of controls, resulting
in an apparent specificity of 91% (72% to 99%). The study
was time-consuming. The mean time to a positive response
was 19.3 6 10.5 min. Of the total patients, 68% (59% to
77%) with a negative response underwent the entire 45-min
testing protocol.
Isoproterenol tilt table testing. Results of several studies
have reported increased positive response when isoprotere-
nol is used in combination with tilt table testing
(5,14,15,17). Positive yield has been estimated to be in the
60% to 85% range, primarily from various multistage,
incremental isoproterenol tilt table protocols. Although
most studies have suggested acceptable specificity of 80% to
90%, Kapoor and Brant (19) reported that specificity was as
low as 35% in 20 younger control subjects during multistage
isoproterenol tilt table testing, and they recommended
caution in the interpretation of results from isoproterenol
tilt table testing in younger persons. Natale et al. (13)
examined the dose-dependent effect of isoproterenol testing
and reported a decrease in specificity during higher doses of
isoproterenol infusion (3 mg/min and 5 mg/min) from that
with a lower dose (1.5 6 0.5 mg/min). The apparent
specificity of a lower isoproterenol tilt table testing was
adequate when the tilt duration was limited to 10 min, as
implemented in our current study. The mean age of the
Table 3. Comparison of Hemodynamics in Patients With a
Vasovagal Response During Both Tests
Heart Rate
(beats/min)
Blood Pressure
(mm Hg)
Systolic Diastolic
Baseline
Passive tilt 72 6 13 139 6 22 70 6 12
Isoproterenol tilt 102 6 19 137 6 26 63 6 14
Mean difference 29 6 19* 2 6 29 7 6 14†
Vasovagal response
Passive tilt 56 6 19 60 6 13 27 6 15
Isoproterenol tilt 79 6 28 68 6 16 33 6 16
Mean difference 23 6 29* 9 6 14† 7 6 14†
Heart rate and blood pressures during a vasovagal response in a given patient were
calculated as the mean from a 20-s continuous, beat-to-beat recording before return
to the supine position.
* p , 0.001. †p , 0.05.
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control population was 41 6 15 years, and the test duration
was 20 min.
Although more positive responses occur during isopro-
terenol testing, the multistage protocol continues to be
time-consuming. In an attempt to reduce testing time,
Sheldon (16) compared single-stage (5 mg/min) with mul-
tistage isoproterenol tilt table testing. Positive response rates
were comparable between the single-stage and the multi-
stage isoproterenol tilt table tests, and the single-stage test
was associated with significant time savings. Specificity from
normal controls was not examined in this study. More
recently, Blanc et al. (26) reported that single-dose isopro-
terenol (5 mg/min) tilt table testing reproduced 95% of
passive tilt responses and saved more time.
For the reasons provided earlier in this article, an inter-
mediate unit dose of isoproterenol at 0.05 mg/kg/min was
selected in our current protocol in this adult patient popu-
lation. A unit dose per kilogram of body weight provides a
more uniform physiologic response and minimizes varia-
tions as a function of body weight. Single-stage isoproter-
enol testing was compared with “standard” tilt table testing.
The positive response rate, 56% (46% to 65%), observed in
our study was in general agreement with the data reported in
the literature. A single-stage isoproterenol tilt table test was
tolerated by all patients and reproduced 77% (60% to 90%)
of the passive tilt table responses. The apparent specificity in
normal subjects (a younger age group) was 83% (61% to
95%). Procedural time was significantly reduced. In the
entire study population, the mean procedural time, includ-
ing 5 min of infusion in the supine position, was 11.7 6
3.6 min.
Isoproterenol versus passive tilt table testing. Differences
exist between single-stage isoproterenol and passive tilt
table testing. Heart rate and blood pressure responses are
significantly different between the two tests both before and
during the development of vasovagal symptoms. The dif-
ferences in hemodynamics before the onset of symptoms are
consistent with findings in our recent report on the different
triggering mechanisms for vasovagal syncope (27). Differ-
ences in hemodynamics during the vasovagal responses raise
caution in the interpretation of laboratory observations and
stress the importance of correlating laboratory observations
to spontaneous clinical presentation.
Gender-related differences in the tilt table responses
could be present. The additional effect of isoproterenol in
eliciting a positive response in more male than female
patients showed a trend toward statistical significance (p 5
0.06). The different responses to orthostatic stress and
isoproterenol between male and female patients may suggest
a gender-dependent mechanism for vasovagal syncope.
Gender-related issues in tilt table testing have not been
explored at this time.
Study limitations. Intrinsic limitations of tilt table testing
have been well outlined in the discussion. Although the
variable observations on the reproducibility of tilt table
testing are well recognized (28–33), a randomized, cross-
over study design such as in our study should minimize type
II errors. The trend toward a higher positive response when
passive tilt was second in sequence could be a result of the
length of the study protocol. Other potential contributing
factors are residual isoproterenol effect, volume shifts pro-
voked by tilt and vasodilation. Age differences between the
patient population and controls may have affected the
apparent specificity observed in our study. However, the
younger controls should provide only the “worst” model for
tilt table specificity on the basis of information available in
the current literature. Intra-arterial blood pressure monitor-
ing may affect the net specificity of the study protocols. A
significant differential effect on each test individually is not
expected, because of the randomized, sequential nature of
the study design.
Clinical implications and conclusions. Results from
our study support the conclusion that single-stage iso-
proterenol tilt table testing at 0.05 mg/kg/min and a 70°
angle for 10 min was more effective in inducing a
vasovagal response than “standard” tilt table testing in
adult patients. This increased positive response was
achieved at a moderate reduction in the apparent speci-
ficity, from 91% (72% to 99%) to 83% (61% to 99%). The
single-stage isoproterenol tilt table test significantly re-
duced procedural time and could be a reasonable alter-
native diagnostic test in patients undergoing syncope
evaluation. Differences in hemodynamic responses be-
tween tests stress the importance of correlating patient’s
clinical presentations to laboratory findings.
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